BENET MIGUEL S 4
4 · COMMUNITY HEALTH SYSTEMS INC · Filed Feb 25, 2025
Insider Transaction Report
Form 4
BENET MIGUEL S
President and CMO
Transactions
- Sale
Common Stock
2025-02-21$3.52/sh−23,875$84,159→ 55,000 total
Holdings
- 30,000
Stock Options (Right to Buy)
Exercise: $6.15From: 2024-03-01Exp: 2033-02-28→ Common Stock (30,000 underlying) - 30,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (30,000 underlying) - 15,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (15,000 underlying) - 30,000
Performance Based Restricted
Exercise: $0.00→ Common Stock (30,000 underlying) - 30,000
Stock Options (Right to Buy)
Exercise: $2.87From: 2025-03-01Exp: 2034-02-28→ Common Stock (30,000 underlying) - 15,000
Stock Options (Right to Buy)
Exercise: $10.18From: 2023-03-01Exp: 2032-02-29→ Common Stock (15,000 underlying)
Footnotes (5)
- [F1]These shares were sold in a series of transactions at a sales price of $3.525 per share.
- [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
- [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
- [F4]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
- [F5]Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.